Impact of Elexacaftor/Tezacaftor/Ivacaftor on Cystic Fibrosis Liver Tests in a Real-World Cohort with and Without Baseline CFLD

被引：0
|
作者：
Bowen, M. [1 ]
Sample, E. [1 ]
Collins, A. [1 ]
Singhal, A. [1 ]
Brown, A. [1 ]
机构：
[1] Inova Fairfax Hosp, Adv Lung Dis & Lung Transplant, Falls Church, VA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2028
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
    Williams, Cindy L.
    Billings, Joanna
    Mcgowan, Harriet
    Mcdevitt, Rebecca
    Esther Jr, Charles R.
    Mckinzie, Cameron J.
    Wilson, William S.
    Kam, Charissa W.
    PEDIATRIC PULMONOLOGY, 2025, 60 (03)
  • [22] Impact of elexacaftor/tezacaftor/ivacaftor on vitamin D absorption in cystic fibrosis patients
    Wright, Brittany A.
    Ketchen, Natalie K.
    Rasmussen, Leah N.
    Bartels, Alyssa R.
    Singh, Sachinkumar B.
    PEDIATRIC PULMONOLOGY, 2022, 57 (03) : 655 - 657
  • [23] Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis
    Marsh, Ryan
    Dos Santos, Claudio
    Yule, Alexander
    Dellschaft, Neele S.
    Hoad, Caroline L.
    Ng, Christabella
    Major, Giles
    Smyth, Alan R.
    Rivett, Damian
    van der Gast, Christopher
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (05) : 967 - 976
  • [24] Elucidating the Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Intolerance in People With Cystic Fibrosis
    Nielsen, Bibi Uhre
    Shaw, James A. M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
  • [25] Olfaction before and after initiation of elexacaftor-tezacaftor-ivacaftor in a cystic fibrosis cohort
    Bacon, Daniel R.
    Stapleton, Amanda
    Goralski, Jennifer L.
    Ebert, Charles S., Jr.
    Thorp, Brian D.
    Nouraie, Mehdi
    Shaffer, Amber D.
    Senior, Brent A.
    Lee, Stella E.
    Zemke, Anna C.
    Kimple, Adam J.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2022, 12 (02) : 223 - 226
  • [26] Comparison of two pregnancies with and without elexacaftor-tezacaftor-ivacaftor in a woman with cystic fibrosis
    Chamagne, Matthieu
    Frarabet, Clemence
    Grenet, Dominique
    Ayoubi, Jean Marc
    RESPIRATORY MEDICINE AND RESEARCH, 2023, 83
  • [27] Impact of elexacaftor/tezacaftor/ivacaftor on muscle strength and exercise capacity in adults with cystic fibrosis: Real-world evidence from a large adult CF centre
    Hall, K.
    Cobb, R.
    Bingham, J.
    Smith, A.
    Reid, D.
    RESPIROLOGY, 2024, 29 : 162 - 162
  • [28] Depression Symptoms in Patients with Cystic Fibrosis Fluctuate at Baseline and Improve with Elexacaftor/Tezacaftor/Ivacaftor Therapy
    Piehler, Linus
    Thalemann, Ralf
    Lehmann, Christine
    Stahl, Mirjam
    Mall, Marcus A.
    Graeber, Simon Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 210 (03) : 365 - 367
  • [29] Elexacaftor/Tezacaftor/Ivacaftor use in Pediatric Cystic Fibrosis Patients with Advanced Liver Disease
    Protich, Hannah E.
    Molleston, Jean P.
    Bozic, Molly
    Pettit, Rebecca S.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (06) : 1122 - 1128
  • [30] Sustained Improvement of Cystic Fibrosis Lung Disease following Initiation of Elexacaftor/Tezacaftor/Ivacaftor Therapy: Lessons from Real-World Studies
    Steinke, Eva
    Stahl, Mirjam
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (09) : 911 - 913
12345